Suppression of NF-κB and NF-κB-regulated gene expression by sulforaphane and PEITC through IκBα, IKK pathway in human prostate cancer PC-3 cells
Open Access
- 18 April 2005
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 24 (28) , 4486-4495
- https://doi.org/10.1038/sj.onc.1208656
Abstract
Recent studies indicate that natural isothiocyanates, such as sulforaphane (SFN) and phenethyl isothiocyanate (PEITC) possess strong antitumor activities in vitro and in vivo. The nuclear factor kappa B (NF-κB) is believed to play an important role in cancer chemoprevention due to its involvement in tumor cell growth, proliferation, angiogenesis, invasion, apoptosis, and survival. In this study, we investigated the effects and the molecular mechanisms of SFN and PEITC on NF-κB transcriptional activation and NF-κB-regulated gene expression in human prostate cancer PC-3 C4 cells. Treatment with SFN (20 and 30 μM) and PEITC (5 and 7.5 μM) significantly inhibited NF-κB transcriptional activity, nuclear transloction of p65, and gene expression of NF-κB-regulated VEGF, cylcin D1, and Bcl-XL in PC-3 C4 cells. To further elucidate the mechanism, we utilized the dominant-negative mutant of inhibitor of NF-κB alpha (IκBα) (SR-IκBα). Analogous to treatments with SFN and PEITC, SR-IκBα also strongly inhibited NF-κB transcriptional activity as well as VEGF, cylcin D1, and Bcl-XL expression. Furthermore, SFN and PEITC also inhibited the basal and UVC-induced phosphorylation of IκBα and blocked UVC-induced IκBα degradation in PC-3 C4 cells. In examining the upstream signaling, we found that the dominant-negative mutant of IKKβ (dnIKKβ) possessed inhibitory effects similar to SFN and PEITC on NF-κB, VEGF, cylcin D1, Bcl-XL as well as IκBα phosphorylation. In addition, treatment with SFN and PEITC potently inhibited phosphorylation of both IKKβ and IKKα and significantly inhibited the in vitro phosphorylation of IκBα mediated by IKKβ. Taken together, these results suggest that the inhibition of SFN and PEITC on NF-κB transcriptional activation as well as NF-κB-regulated VEGF, cyclin D1, and Bcl-XL gene expression is mainly mediated through the inhibition of IKK phosphorylation, particularly IKKβ, and the inhibition of IκBα phosphorylation and degradation, as well as the decrease of nuclear translocation of p65 in PC-3 cells.Keywords
This publication has 35 references indexed in Scilit:
- Protein Farnesyltransferase Inhibitor (SCH 66336) Abolishes NF-κB Activation Induced by Various Carcinogens and Inflammatory Stimuli Leading to Suppression of NF-κB-regulated Gene Expression and Up-regulation of ApoptosisJournal of Biological Chemistry, 2004
- Identification of a p65 Peptide That Selectively Inhibits NF-κ B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-κB-mediated Gene Expression and Up-regulation of ApoptosisJournal of Biological Chemistry, 2004
- Inhibitors of Protein Kinase C (PKC) Prevent Activated TranscriptionPublished by Elsevier ,2004
- Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cellsCarcinogenesis: Integrative Cancer Research, 2004
- Phenylethyl Isothiocyanate Induces Apoptotic Signaling via Suppressing Phosphatase Activity against c-Jun N-terminal KinasePublished by Elsevier ,2002
- Activation of the Heterodimeric IκB Kinase α (IKKα)-IKKβ Complex Is Directional: IKKα Regulates IKKβ under Both Basal and Stimulated ConditionsMolecular and Cellular Biology, 2000
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Potent induction of carcinogen defence enzymes with sulforaphane, a putative prostate cancer chemopreventive agentProstate Cancer and Prostatic Diseases, 1999
- The Protein Kinase C Activator, Phorbol Ester, Elicits Disparate Functional Responses in Androgen-Sensitive and Androgen-Independent Human Prostatic Cancer CellsBiochemical and Biophysical Research Communications, 1998
- Vegetables, Fruit, and Cancer PreventionJournal of the American Dietetic Association, 1996